Target intelligence / Profile preview

Nuclear transition protein 2 (TNP2)

Target
TNP2
Molecular classification
Other (Small basic chromatin protein)
01

Overview

Nuclear transition protein 2 (TNP2, also known as TP2) is a basic nuclear protein expressed in male germ cells, encoded by the human TNP2 gene on chromosome 16[1][7]. It acts during spermatogenesis, specifically in the transitional phase between histone removal and protamine incorporation. TNP2 mediates the exchange of chromosomal proteins by temporarily associating with DNA after histones have been displaced and before protamines are deposited, facilitating proper chromatin compaction required for mature sperm formation. TNP2 activity, along with related transition proteins and specific histone variants, is crucial for sperm DNA condensation and the male germ cell chromatin remodeling process[5][7]. Dysfunction or absence of TNP2 in animal models leads to abnormal sperm chromatin packaging and male infertility, but no therapeutic drugs or clinical biomarkers are currently known[5][7]. TNP2 is classified neither as a receptor, enzyme, transporter, nor a canonical drug target, but rather as a crucial chromatin-associated protein specific to testicular germ cells[7].

Other names
TNP2TP2Transition protein 2 (during histone to protamine replacement)Nuclear transition protein 2TP-2
02

Biological functions

Sperm DNA condensationExchange of chromosomal proteins during spermatogenesisChromatin remodeling in male germ cells
03

Disease associations

Other (No direct established link to major disease classes; associated with male infertility in animal models)

Beyond the preview

Go deeper on Nuclear transition protein 2 (TNP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear transition protein 2 (TNP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call